Stress-related hormone reduces autophagy through the regulation of phosphatidylethanolamine in breast cancer cells

Zhen Zhu,Ruihua Yu,Chao Yang,Dong Li,Jiawei Wang,Wanli Yang,Yonghua Ji,Li Wang,Yaosheng Wang,Feng Jiang

DOI: https://doi.org/10.21037/atm-20-8176

IF: 3.616

2021-01-01

Annals of Translational Medicine

Abstract:BACKGROUND: An increasing number of studies indicate that adrenergic signaling plays a fundamental role in tumor progression and metastasis induced by chronic stress. However, despite the growing attention, an understanding of the mechanisms linking chronic stress and cancer is still insufficient.METHODS: Western blot analysis and transmission electron microscopy (TEM) were used to observe the changes in autophagy level in a breast cancer cell line (MCF-7) after epinephrine treatment. Non-targeted metabolomics was also used to detect MCF-7 metabolites after epinephrine treatment. The xenograft model was used to detect the level of autophagy after epinephrine intervention.RESULTS: The results showed that epinephrine treatment reduced the autophagy level of breast cancer cells. Epinephrine changed the level of phosphatidylethanolamine (PE) in breast cancer cells as detected by non-targeted metabolomics. Epinephrine also changed autophagy in breast cancer cells by decreasing the level of PE in cells. When autophagy decreased, the invasion and migration of breast cancer cells increased <i>in vitro</i>, and the progression of breast cancer accelerated <i>in vivo</i>.CONCLUSIONS: These findings suggest that stress-related hormones affect the tumor progression of breast cancer. Therefore, strengthening the emotional management strategies of patients during the process of antitumor treatment as a supplement to the existing treatments may be beneficial.

oncology,medicine, research & experimental